Literature DB >> 32689841

Characterizing Microbiota from Sjögren's Syndrome Patients.

M Singh1, F Teles2,3, N G Uzel4, A Papas1.   

Abstract

OBJECTIVE: To compare the oral microbiota of Sjögren's syndrome (SS) with that of healthy subjects (HS).
METHODS: Supragingival and subgingival biofilm samples were collected from the mesial-buccal tooth surfaces of SS patients (n = 57) and age- and sex-matched HS (n = 53). Unstimulated saliva and 8 oral tissue samples were taken using a buccal brush. Caries and periodontal measures were recorded. All supragingival samples and a subgroup of 24 SS and 28 HS subgingival samples, as well as 32 SS and 11 HS saliva and oral tissue samples, were analyzed for their content of 41 bacterial species using checkerboard DNA-DNA hybridization. Mean levels (×105 ± SEM) and percentage of DNA probe counts of each species were determined for each sample site and averaged within subjects in the 2 clinical groups. Kruskal-Wallis tests, adjusting for multiple comparisons and cluster analysis, were used for soft tissue and microbial analysis, and the Mann-Whitney test was used to compare caries and periodontal measures.
RESULTS: Mean (×105 ± SEM) total DNA probe counts in supragingival samples were significantly lower (P < 0.001) in the SS (13.3 ± .7) compared to the HS (44.1 ± 6.8) group. In supragingival samples, Veillonella parvula, Fusobacterium nucleatum ss vincenti, and Propionibacterium acnes were markedly elevated in the SS compared to the HS group in both mean (×105 ± SEM) and mean (± SEM) percentage DNA probe counts (P < 0.001). In subgingival samples of SS, V. parvula was significantly different compared to HS (P < 0.05). SS was characterized by high levels of purple and low levels of orange and red complexes. Cluster analysis of oral tissues and saliva demonstrated that the mean microbial profiles for SS patients and the HS group clustered separately. Active root caries (P < 0.003) and attachment loss were significantly higher (P < 0.029) in the SS group compared to the HS group.
CONCLUSION: These findings indicate that saliva is a major controlling factor of intraoral biofilm. V. parvula may be a unique microbial biomarker for Sjögren's syndrome. KNOWLEDGE TRANSFER STATEMENT: The microbiome characterized for Sjögren's syndrome in salivary hypofunction is shown to be under stress and reduced. Veillonella parvula can be a possible identification of a biomarker for Sjögren's syndrome.

Entities:  

Keywords:  DNA-DNA hybridization; Veillonella parvula; bulk fluid; mean and percentages of DNA count; plaque; salivary hypofunction

Year:  2020        PMID: 32689841      PMCID: PMC8209841          DOI: 10.1177/2380084420940623

Source DB:  PubMed          Journal:  JDR Clin Trans Res        ISSN: 2380-0844


  38 in total

1.  Oral involvement in primary Sjögren syndrome.

Authors:  Philip C Fox; Simon J Bowman; Barbara Segal; Frederick B Vivino; Nandita Murukutla; Karen Choueiri; Sarika Ogale; Lachy McLean
Journal:  J Am Dent Assoc       Date:  2008-12       Impact factor: 3.634

2.  The oral microbiome - an update for oral healthcare professionals.

Authors:  M Kilian; I L C Chapple; M Hannig; P D Marsh; V Meuric; A M L Pedersen; M S Tonetti; W G Wade; E Zaura
Journal:  Br Dent J       Date:  2016-11-18       Impact factor: 1.626

Review 3.  Role of the microbiota in immunity and inflammation.

Authors:  Yasmine Belkaid; Timothy W Hand
Journal:  Cell       Date:  2014-03-27       Impact factor: 41.582

4.  Effect of Veillonella parvula on the antimicrobial resistance and gene expression of Streptococcus mutans grown in a dual-species biofilm.

Authors:  S B I Luppens; D Kara; L Bandounas; M J Jonker; F R A Wittink; O Bruning; T M Breit; J M Ten Cate; W Crielaard
Journal:  Oral Microbiol Immunol       Date:  2008-06

5.  Supra-gingival microbiota in Sjögren's syndrome.

Authors:  K C M Leung; W K Leung; A S McMillan
Journal:  Clin Oral Investig       Date:  2007-07-03       Impact factor: 3.573

6.  Discovery of putative salivary biomarkers for Sjögren's syndrome using high resolution mass spectrometry and bioinformatics.

Authors:  Driss Zoukhri; Ian Rawe; Mabi Singh; Ashley Brown; Claire L Kublin; Kevin Dawson; William F Haddon; Earl L White; Kathleen M Hanley; Daniel Tusé; Wasyl Malyj; Athena Papas
Journal:  J Oral Sci       Date:  2012-03       Impact factor: 1.630

7.  Altered Mucosal Microbiome Diversity and Disease Severity in Sjögren Syndrome.

Authors:  Cintia S de Paiva; Dan B Jones; Michael E Stern; Fang Bian; Quianta L Moore; Shani Corbiere; Charles F Streckfus; Diane S Hutchinson; Nadim J Ajami; Joseph F Petrosino; Stephen C Pflugfelder
Journal:  Sci Rep       Date:  2016-04-18       Impact factor: 4.379

8.  Isolation of Propionibacterium acnes among the microbiota of primary endodontic infections with and without intraoral communication.

Authors:  Sadia Ambreen Niazi; Hana Suleiman Al Kharusi; Shanon Patel; Kenneth Bruce; David Beighton; Federico Foschi; Francesco Mannocci
Journal:  Clin Oral Investig       Date:  2016-02-09       Impact factor: 3.573

9.  Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity.

Authors:  Thomas Mandl; Jan Marsal; Peter Olsson; Bodil Ohlsson; Kristofer Andréasson
Journal:  Arthritis Res Ther       Date:  2017-10-24       Impact factor: 5.156

10.  Patients with chronic periodontitis present increased risk for primary Sjögren syndrome: a nationwide population-based cohort study.

Authors:  Tai-Chen Lin; Chien-Fang Tseng; Yu-Hsun Wang; Hui-Chieh Yu; Yu-Chao Chang
Journal:  PeerJ       Date:  2018-06-20       Impact factor: 2.984

View more
  2 in total

Review 1.  Interconnections Between the Oral and Gut Microbiomes: Reversal of Microbial Dysbiosis and the Balance Between Systemic Health and Disease.

Authors:  Brandon Khor; Michael Snow; Elisa Herrman; Nicholas Ray; Kunal Mansukhani; Karan A Patel; Nasser Said-Al-Naief; Tom Maier; Curtis A Machida
Journal:  Microorganisms       Date:  2021-02-26

Review 2.  A Glimpse Into the Microbiome of Sjögren's Syndrome.

Authors:  Chuiwen Deng; Qiufeng Xiao; Yunyun Fei
Journal:  Front Immunol       Date:  2022-07-14       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.